264 related articles for article (PubMed ID: 26599598)
1. Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.
Mishra M; Flaga J; Kowluru RA
J Cell Physiol; 2016 Aug; 231(8):1709-18. PubMed ID: 26599598
[TBL] [Abstract][Full Text] [Related]
2. Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.
Mishra M; Kowluru RA
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1761-1769. PubMed ID: 28478229
[TBL] [Abstract][Full Text] [Related]
3. Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.
Kowluru RA; Santos JM; Zhong Q
Invest Ophthalmol Vis Sci; 2014 Jun; 55(9):5653-60. PubMed ID: 24894401
[TBL] [Abstract][Full Text] [Related]
4. Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras.
Kowluru RA
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4320-6. PubMed ID: 20220057
[TBL] [Abstract][Full Text] [Related]
5. Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.
Kowluru RA; Shan Y
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):955-962. PubMed ID: 28124145
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.
Kowluru RA; Mohammad G; dos Santos JM; Zhong Q
Diabetes; 2011 Nov; 60(11):3023-33. PubMed ID: 21933988
[TBL] [Abstract][Full Text] [Related]
7. Sirt1: A Guardian of the Development of Diabetic Retinopathy.
Mishra M; Duraisamy AJ; Kowluru RA
Diabetes; 2018 Apr; 67(4):745-754. PubMed ID: 29311218
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.
Kowluru RA; Kanwar M
Free Radic Biol Med; 2009 Jun; 46(12):1677-85. PubMed ID: 19345729
[TBL] [Abstract][Full Text] [Related]
9. Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy.
Kowluru RA; Shan Y; Mishra M
Lab Invest; 2016 Oct; 96(10):1040-9. PubMed ID: 27454437
[TBL] [Abstract][Full Text] [Related]
10. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.
Zhong Q; Kowluru RA
Diabetes; 2013 Jul; 62(7):2559-68. PubMed ID: 23423566
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
Duraisamy AJ; Mishra M; Kowluru RA
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6440-6448. PubMed ID: 29261844
[TBL] [Abstract][Full Text] [Related]
12. Diabetic retinopathy and transcriptional regulation of a small molecular weight G-Protein, Rac1.
Kowluru RA; Mishra M; Kumar B
Exp Eye Res; 2016 Jun; 147():72-77. PubMed ID: 27109029
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation.
Mohammad G; Kowluru RA
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150828
[TBL] [Abstract][Full Text] [Related]
14. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
[TBL] [Abstract][Full Text] [Related]
15. Sirtuin 1 is a negative regulator of parathyroid hormone stimulation of matrix metalloproteinase 13 expression in osteoblastic cells: role of sirtuin 1 in the action of PTH on osteoblasts.
Fei Y; Shimizu E; McBurney MW; Partridge NC
J Biol Chem; 2015 Mar; 290(13):8373-82. PubMed ID: 25631045
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.
Crowe DL; Brown TN
Neoplasia; 1999 Oct; 1(4):368-72. PubMed ID: 10935492
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Modifications Compromise Mitochondrial DNA Quality Control in the Development of Diabetic Retinopathy.
Mohammad G; Radhakrishnan R; Kowluru RA
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3943-3951. PubMed ID: 31546260
[TBL] [Abstract][Full Text] [Related]
18. p38 promoted retinal micro-angiogenesis through up-regulated RUNX1 expression in diabetic retinopathy.
Zou W; Zhang Z; Luo S; Cheng L; Huang X; Ding N; Yu J; Pan Y; Wu Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32319515
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of Smad3-deficient mice.
Xu B; Chen H; Xu W; Zhang W; Buckley S; Zheng SG; Warburton D; Kolb M; Gauldie J; Shi W
Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(2):L89-96. PubMed ID: 22610349
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1.
Mortuza R; Feng B; Chakrabarti S
J Cell Mol Med; 2015 Aug; 19(8):1857-67. PubMed ID: 25753689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
